Literature DB >> 6352456

Histiocytosis X in the lung.

T V Colby, C Lombard.   

Abstract

The histologic and clinical features of pulmonary histiocytosis X are discussed. The majority of patients are in the third and fourth decades of life. They present with nonspecific respiratory complaints and bilateral reticulonodular infiltrates that can be seen on chest radiographs. The histologic lesions of pulmonary histiocytosis X are scattered, discrete nodules that frequently center on small airways. The initially cellular nodules are replaced progressively by fibrous tissue. The cell infiltrates in active lesions contain variable numbers of eosinophils and histiocytes resembling Langerhans cells of the epidermis (Hx cells). In most patients the disease resolves or stabilizes, leaving few, if any, significant residues. A minority of patients develop progressive pulmonary disease that is ultimately fatal. The cause of pulmonary histiocytosis X is unknown, but two recent series suggest a relationship to cigarette smoking.

Entities:  

Mesh:

Year:  1983        PMID: 6352456     DOI: 10.1016/s0046-8177(83)80160-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  21 in total

Review 1.  Adult pulmonary Langerhans' cell histiocytosis.

Authors:  A Tazi; P Soler; A J Hance
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

Review 2.  Rare lung diseases III: pulmonary Langerhans' cell histiocytosis.

Authors:  Stephen C Juvet; David Hwang; Gregory P Downey
Journal:  Can Respir J       Date:  2010 May-Jun       Impact factor: 2.409

3.  Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis.

Authors:  Sergio Harari; Olga Torre; Roberto Cassandro; Angelo M Taveira-DaSilva; Joel Moss
Journal:  Respir Med       Date:  2012-07-07       Impact factor: 3.415

4.  Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X.

Authors:  A Tazi; M Bonay; A Bergeron; M Grandsaigne; A J Hance; P Soler
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

Review 5.  Diffuse Cystic Lung Disease. Part I.

Authors:  Nishant Gupta; Robert Vassallo; Kathryn A Wikenheiser-Brokamp; Francis X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2015-06-15       Impact factor: 21.405

Review 6.  Unusual causes of pneumothorax.

Authors:  Daniel R Ouellette; Scott Parrish; Robert F Browning; J Francis Turner; Konstantinos Zarogoulidis; Ioanna Kougioumtzi; Georgios Dryllis; Ioannis Kioumis; Georgia Pitsiou; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Theodora Tsiouda; Athanasios Madesis; Theodoros Karaiskos; Paul Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

7.  Spontaneous pneumothorax in a case of pulmonary langerhans cell histiocytosis.

Authors:  Adrian Ciuche; Claudiu Nistor; Daniel Pantile; Dragos Marin; Augustin Tudose
Journal:  Maedica (Bucur)       Date:  2011-07

8.  Isolated pulmonary histiocytosis.

Authors:  H P McDowell; P I Macfarlane; J Martin
Journal:  Arch Dis Child       Date:  1988-04       Impact factor: 3.791

9.  Pulmonary histiocytosis X.

Authors:  T W Marcy; H Y Reynolds
Journal:  Lung       Date:  1985       Impact factor: 2.584

10.  Diagnostic relevance of Langerin detection in cells from bronchoalveolar lavage of patients with pulmonary Langerhans cell histiocytosis, sarcoidosis and idiopathic pulmonary fibrosis.

Authors:  Karel Smetana; Otakar Mericka; Sem Saeland; Jirí Homolka; Jirí Brabec; Hans-Joachim Gabius
Journal:  Virchows Arch       Date:  2004-01-13       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.